circRIMS has potential as an early biomarker for use in predicting invasive metastasis in GC and to guide clinical diagnosis and treatment for precision medicine.
CircRNA CircRIMS Acts as a MicroRNA Sponge to Promote Gastric Cancer Metastasis.